Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
For best results when printing this announcement, please click on link below: Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026 INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results
On Thursday, Shoulder Innovations (NYSE: SI ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Shoulder Innovations reported a 56% ye
Eli Lilly (NYSE: LLY ) held its second-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. View the webcast at Summary Full Transcript OPERATOR Ladies and gentlemen, thank you f
Teleflex (NYSE: TFX ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at
Merck & Co.'s KEYTRUDA QLEX (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous use has been approved by Japan's Ministry of Health, Labor and Welfare for all indications previously approved for KEYTRUDA. KEYJECT, the planned trademark for KEYTRUDA QLEX in Japan, can be administered in as little
D Specialty Surgical Center LLC files with SEC, disclosure details unknown